arrow
A

Andrés Esteban-Cantos

hospital la paz institute for health research
H指数:15
被引数:651

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial

二甲双胍与表观遗传年龄在马德里非糖尿病HIV老年人群中的关系(METFORAGING):一项双盲、随机、安慰剂对照的试点试验

2026-04-180
OAAI
DNA N6-methyladenine and ABCA1 methylation associations with subclinical coronary atherosclerosis in people with HIV

人类免疫缺陷病毒感染者中DNA N6-甲基腺嘌呤和ABCA1甲基化与亚临床冠状动脉粥样硬化的关联

2025-10-050
OAAI
Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled Human Immunodeficiency Virus (HIV-1) Infection

血源性表观遗传衰老标志物在人类免疫缺陷病毒(HIV-1)感染得到良好控制的人群中的预后价值

2025-10-010
OA
Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1
2024-09-231
OAAI
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years
2023-05-0115
OA
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) (vol 55, 102779, 2020)
2023-03-011
OAAI
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns
2023-02-0110
OAAI
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
2022-11-086
OAAI
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)
2021-08-306
PRE
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment
2021-06-2417
PRE
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
2020-11-1725
PREAI
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
2020-05-0128
OAAI
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1
2018-07-0325
OAAI
Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-Infected Adults
2018-06-1525
OAAI